30.75

2.77% 0.83

Tectonic Therapeutic Inc (TECX)

Overview News Price History Discussions Forecast

Tectonic Therapeutic Inc stock is traded at $30.75, with a volume of 159.29K. It is up +2.77% in the last 24 hours and up +5.42% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Previous Close:

$29.92

Open:

$29.85

24h Volume:

159.29K

Relative Volume:

0.85

Market Cap:

$601.14M

Revenue:

Net Income/Loss:

$-83.49M

P/E Ratio:

-6.8993

EPS:

-4.457

Net Cash Flow:

$-60.29M

1W Performance:

-13.67%

1M Performance:

+5.42%

6M Performance:

+12.19%

1Y Performance:

+78.05%

1-Day Range:

$29.73

$31.12

1-Week Range:

$28.96

$35.67

52-Week Range:

$14.38

$39.53

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name

Tectonic Therapeutic Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(339) 666-3320

Address

490 ARSENAL WAY, WATERTOWN

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

TECX's Discussions on Twitter

Compare TECX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECX Tectonic Therapeutic Inc	30.75	704.75M	0	-83.49M	-60.29M	-4.457
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-26-26	Upgrade	Raymond James	Outperform → Strong Buy
Apr-14-26	Initiated	Stifel	Buy
Oct-20-25	Initiated	Wells Fargo	Overweight
Sep-03-25	Initiated	Oppenheimer	Outperform
Jul-21-25	Initiated	Truist	Buy
Jun-11-25	Resumed	Raymond James	Outperform
Apr-21-25	Initiated	Mizuho	Outperform
Nov-20-24	Initiated	Raymond James	Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Jun-26-24	Initiated	Piper Sandler	Overweight
Jun-24-24	Initiated	TD Cowen	Buy
Dec-18-23	Downgrade	Mizuho	Buy → Neutral
Jan-05-22	Downgrade	BTIG Research	Buy → Neutral
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-15-21	Initiated	BTIG Research	Buy
May-27-21	Initiated	Needham	Buy
Mar-09-21	Initiated	Barclays	Overweight
Mar-02-21	Initiated	Stifel	Hold
Nov-11-20	Initiated	Berenberg	Buy
Mar-31-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-19	Initiated	Mizuho	Buy
Apr-05-19	Initiated	Janney	Buy
Oct-10-18	Initiated	Guggenheim	Buy
Oct-02-18	Reiterated	H.C. Wainwright	Buy
Sep-17-18	Initiated	H.C. Wainwright	Buy
Jul-16-18	Initiated	Wedbush	Outperform
Jul-16-18	Initiated	Wells Fargo	Outperform

View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

Aug 21, 2026

Tectonic Therapeutic (NASDAQ: TECX) ex-director to sell 10,200 shares - Stock Titan

Aug 21, 2026

Aug 20, 2026

Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research - MarketBeat

Aug 20, 2026

Aug 18, 2026

Tectonic Therapeutic (NASDAQ:TECX) Trading 5.6% HigherShould You Buy? - MarketBeat

Aug 18, 2026

Aug 14, 2026

Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com

Aug 14, 2026

Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India

Aug 14, 2026

Aug 12, 2026

TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan

Aug 12, 2026

Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - MarketBeat

Aug 12, 2026

Aug 10, 2026

Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $60 - Moomoo

Aug 10, 2026

Aug 08, 2026

Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo

Aug 08, 2026

Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat

Aug 08, 2026

Aug 07, 2026